Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Dr. Kornblum on Results of PrECOG 0102 in Breast Cancer

March 6th 2017

Noah S. Kornblum, MD, assistant professor of medicine, Albert Einstein College of Medicine, attending physician of medicine, Montefiore-Einstein Center for Cancer Care, discusses the results from the PrECOG 0102 study, which explored the addition of everolimus (Afinitor) to fulvestrant (Faslodex) as a treatment for patients with metastatic hormone receptor (HR)–positive, HER2-negative breast cancer.

Adjuvant Pertuzumab Succeeds in Phase III HER2+ Breast Cancer Trial

March 2nd 2017

Adding pertuzumab (Perjeta) to trastuzumab (Herceptin) and chemotherapy reduced the risk of recurrence of invasive disease or death in patients with HER2-positive early breast cancer, according to findings from the phase III APHINITY study.

Breast Cancer Brain Metastases Require Personalized Approach

February 28th 2017

Carey Anders, MD, discusses available and emerging treatment options for patients with breast cancer that has metastasized to the brain.

Antibody-Drug Conjugates for TNBC

February 22nd 2017

Immunotherapy for TNBC

February 22nd 2017

BRCA1/2 Status and Homologous Repair Deficiency in TNBC

February 22nd 2017

Treating HER2+ Metastatic Breast Cancer

February 22nd 2017

Extended Adjuvant Therapy for HER2+ Early Breast Cancer

February 22nd 2017

HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer

February 22nd 2017

PI3K Inhibitors in HR+ Metastatic Breast Cancer

February 22nd 2017

Everolimus for HR+ Metastatic Breast Cancer

February 22nd 2017

Emerging Role of Abemaciclib for HR+ Advanced Breast Cancer

February 22nd 2017

Ribociclib for HR+ Advanced Breast Cancer

February 22nd 2017

FALCON Trial Data in HR+ Metastatic Breast Cancer

February 22nd 2017

Breast Cancer: Extended Adjuvant Endocrine Therapy

February 22nd 2017

Comparison of Prognostic Tests in Breast Cancer

February 22nd 2017

Breast Cancer: Genomic Testing

February 22nd 2017

MINDACT Trial Design and Results in Breast Cancer

February 22nd 2017

Breast Cancer: Genomic Testing for Adjuvant Therapy

February 22nd 2017

Dr. White on CNS Metastases in HER2+ Breast Cancer

February 22nd 2017

Julia White, MD, The Ohio State University Comprehensive Cancer Center, discusses brain metastases in patients with HER2-positive breast cancer.